Osimertinib Interactions
There are 619 drugs known to interact with osimertinib, along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 254 are major, 316 are moderate, and 49 are minor.
- View all 619 medications that may interact with osimertinib
- View osimertinib alcohol/food interactions (1)
- View osimertinib disease interactions (6)
Most frequently checked interactions
View interaction reports for osimertinib and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Activated Charcoal (charcoal)
- Adriamycin (doxorubicin)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Anusol (pramoxine/zinc oxide topical)
- AquADEKs (multivitamin with minerals)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Atarax (hydroxyzine)
- Belsomra (suvorexant)
- Benadryl (diphenhydramine)
- Biotene Mouthwash (saliva substitutes topical)
- Celebrex (celecoxib)
- Cernevit (multivitamin)
- Childrens Chewable Multivitamins (multivitamin)
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Fleet Enema (sodium biphosphate / sodium phosphate)
- Lipitor (atorvastatin)
- Metoprolol Tartrate (metoprolol)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Paracetamol (acetaminophen)
- Retinol (vitamin a topical)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
Osimertinib alcohol/food interactions
There is 1 alcohol/food interaction with osimertinib.
Osimertinib disease interactions
There are 6 disease interactions with osimertinib which include:
- cardiomyopathy
- dermatologic toxicities
- ocular disorders
- pulmonary toxicity
- QT prolongation
- renal/liver impairment
Report options
More about osimertinib
- osimertinib consumer information
- Compare alternatives
- Reviews (41)
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
